ROSA® Knee System V1.5 Pilot Study
Launched by ZIMMER BIOMET · May 29, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The ROSA® Knee System V1.5 Pilot Study is a research project designed to test the safety and usability of a new version of the ROSA® Knee System, which is a robotic tool used during knee surgery for patients with knee osteoarthritis and other joint diseases. The main goal of this study is to see how well the robotic system works during surgery and to understand how satisfied surgeons are with its performance. This study is not yet recruiting participants, but it will include adults aged 18 and older who are scheduled for a total knee replacement surgery.
To participate, patients must be eligible for knee surgery using standard implants and be willing to sign a consent form. However, individuals who are pregnant, currently participating in other related studies, or have had previous knee surgery on the same knee cannot take part. Participants can expect to help provide important information that may lead to improvements in robotic knee surgery, while also ensuring that the system is safe for future use.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient is a minimum of 18 years of age
- • Independent of study participation, patient is a candidate for primary total knee arthroplasty using commercially available and compatible implants in accordance with product labeling
- • Patient is willing and able to provide written Informed Consent by signing and dating the EC approved Informed Consent form
- Exclusion Criteria:
- • Patient is currently participating in any other surgical intervention studies or pain management studies
- • Patient is pregnant or considered a member of a protected population (e.g., prisoner, mentally incompetent, etc.)
- • Patient has previously received partial or total knee arthroplasty for the ipsilateral knee
About Zimmer Biomet
Zimmer Biomet is a leading global medical technology company specializing in the design, development, and manufacturing of innovative orthopedic and surgical products. With a commitment to enhancing patient outcomes, Zimmer Biomet focuses on advancing musculoskeletal health through a broad range of solutions, including joint reconstruction, surgical instrumentation, and dental implants. The company emphasizes research and development, conducting numerous clinical trials to evaluate the safety and effectiveness of its products, while fostering collaboration with healthcare professionals to address the evolving needs of patients and providers alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported